Analysis of the tumor microenvironment reveals that G36-PDL1 CAR-T cells enhance anti-tumor immunity by stimulating cytotoxic tumor-killing, decreasing immunosuppressive cells such as M2 macrophages and exhausted CD8 + T cells, and promoting interactions between Tfh cells and B cells. Here, CD8A is linked to neoplasm.